| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.34 | 8e-10 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.22 | 5e-08 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |